Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques

References

• Perry RD, Fetherston JD. Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev 1997; 10:35 - 66; PMID: 8993858
   PubMed Web of Science ®Google Scholar
• Williamson ED. Plague vaccine research and development. J Appl Microbiol 2001; 91:606 - 8; http://dx.doi.org/10.1046/j.1365-2672.2001.01497.x; PMID: 11576295
   PubMed Web of Science ®Google Scholar
• Riedel S. Plague: from natural disease to bioterrorism. Proc (BaylUniv Med Cent) 2005; 18:116 - 24; PMID: 16200159
   PubMedGoogle Scholar
• Wang H, Cui Y, Wang Z, Wang X, Guo Z, Yan Y, Li C, Cui B, Xiao X, Yang Y, et al. A dog-associated primary pneumonic plague in Qinghai Province, China. Clin Infect Dis 2011; 52:185 - 90; http://dx.doi.org/10.1093/cid/ciq107; PMID: 21288842
   PubMed Web of Science ®Google Scholar
• Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995; 13:1551 - 6; http://dx.doi.org/10.1016/0264-410X(95)00090-N; PMID: 8578841
   PubMed Web of Science ®Google Scholar
• Titball RW, Williamson ED. Yersinia pestis (plague) vaccines. Expert OpinBiolTher 2004; 4:965 - 73; http://dx.doi.org/10.1517/14712598.4.6.965; PMID: 15174978
   PubMed Web of Science ®Google Scholar
• Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 2005; 73:7304 - 10; http://dx.doi.org/10.1128/IAI.73.11.7304-7310.2005; PMID: 16239527
   PubMed Web of Science ®Google Scholar
• Philipovskiy AV, Smiley ST. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun 2007; 75:878 - 85; http://dx.doi.org/10.1128/IAI.01529-06; PMID: 17118978
   PubMed Web of Science ®Google Scholar
• Morton M, Garmory HS, Perkins SD, O’Dowd AM, Griffin KF, Turner AK, Bennett AM, Titball RW. A Salmonella entericaserovarTyphi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine 2004; 22:2524 - 32; http://dx.doi.org/10.1016/j.vaccine.2004.01.007; PMID: 15193377
   PubMed Web of Science ®Google Scholar
• Williamson ED, Eley SM, Griffin KF, Green M, Russell P, Leary SE, Oyston PC, Easterbrook T, Reddin KM, Robinson A, et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 1995; 12:223 - 30; http://dx.doi.org/10.1111/j.1574-695X.1995.tb00196.x; PMID: 8745007
   PubMed Web of Science ®Google Scholar
• Rosenzweig JA, Chopra AK. The future of plague vaccines: hopes raised by a surrogate, live-attenuated recombinant vaccine candidate. Expert Rev Vaccines 2012; 11:659 - 61; http://dx.doi.org/10.1586/erv.12.34; PMID: 22873124
   PubMed Web of Science ®Google Scholar
• Derbise A, CerdàMarín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.. PLoSNegl Trop Dis 2012; 6:e1528; http://dx.doi.org/10.1371/journal.pntd.0001528; PMID: 22348169
   PubMedGoogle Scholar
• Sizemore DR, Warner EA, Lawrence JA, Thomas LJ, Roland KL, Killeen KP. Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates. Hum VaccinImmunother 2012; 8:371 - 83; http://dx.doi.org/10.4161/hv.18670; PMID: 22327496
   PubMed Web of Science ®Google Scholar
• Mizel SB, Graff AH, Sriranganathan N, Ervin S, Lees CJ, Lively MO, Hantgan RR, Thomas MJ, Wood J, Bell B. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol 2009; 16:21 - 8; http://dx.doi.org/10.1128/CVI.00333-08; PMID: 18987167
   PubMed Web of Science ®Google Scholar
• Garmory HS, Freeman D, Brown KA, Titball RW. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine 2004; 22:947 - 57; http://dx.doi.org/10.1016/j.vaccine.2003.09.020; PMID: 15161071
   PubMed Web of Science ®Google Scholar
• Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect Immun 2003; 71:374 - 83; http://dx.doi.org/10.1128/IAI.71.1.374-383.2003; PMID: 12496187
   PubMed Web of Science ®Google Scholar
• Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. MicrobPathog 1997; 23:167 - 79; http://dx.doi.org/10.1006/mpat.1997.0141; PMID: 9281474
   PubMed Web of Science ®Google Scholar
• Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 2004; 22:3348 - 57; http://dx.doi.org/10.1016/j.vaccine.2004.02.036; PMID: 15308359
   PubMed Web of Science ®Google Scholar
• Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW Jr., Pitt ML, Estep J, Davis K. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.. Clin Infect Dis 1995; 21:Suppl 2 S178 - 81; http://dx.doi.org/10.1093/clinids/21.Supplement_2.S178; PMID: 8845449
   PubMed Web of Science ®Google Scholar
• Heath DG, Anderson GW Jr., Mauro JM, Welkos SL, Andrews GP, Adamovicz J, Friedlander AM. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998; 16:1131 - 7; http://dx.doi.org/10.1016/S0264-410X(98)80110-2; PMID: 9682370
   PubMed Web of Science ®Google Scholar
• Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, Welkos S. Development of in vitro correlate assays of immunity to infection with Yersinia pestis.. Clin Vaccine Immunol 2007; 14:605 - 16; http://dx.doi.org/10.1128/CVI.00398-06; PMID: 17376861
   PubMed Web of Science ®Google Scholar
• Smiley ST. Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 2008; 7:209 - 21; http://dx.doi.org/10.1586/14760584.7.2.209; PMID: 18324890
   PubMed Web of Science ®Google Scholar
• Qi Z, Zhou L, Zhang Q, Ren L, Dai R, Wu B, Wang T, Zhu Z, Yang Y, Cui B, et al. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Vaccine 2010; 28:1655 - 60; http://dx.doi.org/10.1016/j.vaccine.2009.02.078; PMID: 20079562
   PubMed Web of Science ®Google Scholar
• Do Y, Park CG, Kang YS, Park SH, Lynch RM, Lee H, Powell BS, Steinman RM. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur J Immunol 2008; 38:20 - 9; http://dx.doi.org/10.1002/eji.200737799; PMID: 18081041
   PubMed Web of Science ®Google Scholar
• Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 1997; 15:1079 - 84; http://dx.doi.org/10.1016/S0264-410X(96)00303-9; PMID: 9269050
   PubMed Web of Science ®Google Scholar
• Smiley ST. Immune defense against pneumonic plague. Immunol Rev 2008; 225:256 - 71; http://dx.doi.org/10.1111/j.1600-065X.2008.00674.x; PMID: 18837787
   PubMed Web of Science ®Google Scholar
• Bennett AM, Phillpotts RJ, Perkins SD, Jacobs SC, Williamson ED. Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine 1999; 18:588 - 96; http://dx.doi.org/10.1016/S0264-410X(99)00317-5; PMID: 10547416
   PubMed Web of Science ®Google Scholar
• Anisimov AP, Shaikhutdinova RZ, Pan’kina LN, Feodorova VA, Savostina EP, Bystrova OV, Lindner B, Mokrievich AN, Bakhteeva IV, Titareva GM, et al. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice. J Med Microbiol 2007; 56:443 - 53; http://dx.doi.org/10.1099/jmm.0.46880-0; PMID: 17374882
   PubMed Web of Science ®Google Scholar
• Feodorova VA, Pan’kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, et al. A Yersinia pestislpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 2007; 25:7620 - 8; http://dx.doi.org/10.1016/j.vaccine.2007.08.055; PMID: 17913308
   PubMed Web of Science ®Google Scholar
• Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection. Infect Immun 2010; 78:1284 - 93; http://dx.doi.org/10.1128/IAI.00976-09; PMID: 20065026
   PubMed Web of Science ®Google Scholar
• Szaba FM, Kummer LW, Wilhelm LB, Lin JS, Parent MA, Montminy-Paquette SW, Lien E, Johnson LL, Smiley ST. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Infect Immun 2009; 77:4295 - 304; http://dx.doi.org/10.1128/IAI.00273-09; PMID: 19620344
   PubMed Web of Science ®Google Scholar
• Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, Tammariello R. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 2002; 20:2206 - 14; http://dx.doi.org/10.1016/S0264-410X(02)00119-6; PMID: 12009274
   PubMed Web of Science ®Google Scholar
• Fan Z, Ruo Y, Wang S, Jin L, Zhou X, Liu J, Zhang Y, Li F. Microtusbrandti plague in the XilinGol Grassland was inoffensive to humans. Chin J Control Endem Dis 1995; 10:56 - 7
   Google Scholar
• Song Y, Tong Z, Wang J, Wang L, Guo Z, Han Y, Zhang J, Pei D, Zhou D, Qin H, et al. Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res 2004; 11:179 - 97; http://dx.doi.org/10.1093/dnares/11.3.179; PMID: 15368893
   PubMed Web of Science ®Google Scholar
• Fetherston JD, Schuetze P, Perry RD. Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by a repetitive element. MolMicrobiol 1992; 6:2693 - 704; http://dx.doi.org/10.1111/j.1365-2958.1992.tb01446.x; PMID: 1447977
   PubMed Web of Science ®Google Scholar
• Girard G. [IMMUNITY IN PLAGUE. ACQUISITIONS SUPPLIED BY 30 YEARS OF WORK ON THE “PASTEURELLA PESTIS EV” (GIRARD AND ROBIC) STRAIN]. Biol Med (Paris) 1963; 52:631 - 731; PMID: 14095162
   PubMedGoogle Scholar
• Meyer KF, Smith G, Foster L, Brookman M, Sung M. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis 1974; 129:Suppl S85 - 12; http://dx.doi.org/10.1093/infdis/129.Supplement_1.S85; PMID: 4207627
   PubMed Web of Science ®Google Scholar
• Une T, Brubaker RR. In vivo comparison of avirulentVwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun 1984; 43:895 - 900; PMID: 6365786
   PubMed Web of Science ®Google Scholar
• Frank KM, Schneewind O, Shieh W-J. Investigation of a researcher’s death due to septicemic plague. N Engl J Med 2011; 364:2563 - 4; http://dx.doi.org/10.1056/NEJMc1010939; PMID: 21714673
   PubMed Web of Science ®Google Scholar
• Green M, Rogers D, Russell P, Stagg AJ, Bell DL, Eley SM, Titball RW, Williamson ED. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis.. FEMS Immunol Med Microbiol 1999; 23:107 - 13; http://dx.doi.org/10.1111/j.1574-695X.1999.tb01229.x; PMID: 10076907
   PubMed Web of Science ®Google Scholar
• Lee-Lewis H, Anderson DM. Absence of inflammation and pneumonia during infection with nonpigmentedYersinia pestis reveals a new role for the pgm locus in pathogenesis. Infect Immun 2010; 78:220 - 30; http://dx.doi.org/10.1128/IAI.00559-09; PMID: 19841077
   PubMed Web of Science ®Google Scholar
• Fetherston JD, Kirillina O, Bobrov AG, Paulley JT, Perry RD. The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun 2010; 78:2045 - 52; http://dx.doi.org/10.1128/IAI.01236-09; PMID: 20160020
   PubMed Web of Science ®Google Scholar
• Fields KA, Nilles ML, Cowan C, Straley SC. Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun 1999; 67:5395 - 408; PMID: 10496922
   PubMed Web of Science ®Google Scholar
• Nilles ML, Williams AW, Skrzypek E, Straley SC. Yersinia pestisLcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J Bacteriol 1997; 179:1307 - 16; PMID: 9023216
   PubMed Web of Science ®Google Scholar
• Fields KA, Straley SC. LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism. Infect Immun 1999; 67:4801 - 13; PMID: 10456934
   PubMed Web of Science ®Google Scholar
• Cowan C, Philipovskiy AV, Wulff-Strobel CR, Ye Z, Straley SC. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 2005; 73:6127 - 37; http://dx.doi.org/10.1128/IAI.73.9.6127-6137.2005; PMID: 16113334
   PubMed Web of Science ®Google Scholar
• Nilles ML, Fields KA, Straley SC. The V antigen of Yersinia pestis regulates Yopvectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol 1998; 180:3410 - 20; PMID: 9642196
   PubMed Web of Science ®Google Scholar
• Nakajima R, Brubaker RR. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993; 61:23 - 31; PMID: 8418045
   PubMed Web of Science ®Google Scholar
• Parent MA, Wilhelm LB, Kummer LW, Szaba FM, Mullarky IK, Smiley ST. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun 2006; 74:3381 - 6; http://dx.doi.org/10.1128/IAI.00185-06; PMID: 16714568
   PubMed Web of Science ®Google Scholar
• O’Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8:275 - 83; http://dx.doi.org/10.1016/S1074-7613(00)80533-6; PMID: 9529145
   PubMed Web of Science ®Google Scholar
• Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10:385 - 409; http://dx.doi.org/10.1146/annurev.iy.10.040192.002125; PMID: 1590992
   PubMed Web of Science ®Google Scholar
• Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787 - 93; http://dx.doi.org/10.1038/383787a0; PMID: 8893001
   PubMed Web of Science ®Google Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:565 - 8; http://dx.doi.org/10.1038/33340; PMID: 9560152
   PubMed Web of Science ®Google Scholar
• Sin J, Kim JJ, Pachuk C, Satishchandran C, Weiner DB. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J Virol 2000; 74:11173 - 80; http://dx.doi.org/10.1128/JVI.74.23.11173-11180.2000; PMID: 11070014
   PubMed Web of Science ®Google Scholar
• Nakajima H, Kobayashi M, Pollard RB, Suzuki F. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J LeukocBiol 2001; 70:374 - 80; PMID: 11527986
   PubMed Web of Science ®Google Scholar
• Lit LC, Wong C-K, Tam L-S, Li EK-M, Lam CW-K. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006; 65:209 - 15; http://dx.doi.org/10.1136/ard.2005.038315; PMID: 15975968
   PubMed Web of Science ®Google Scholar
• Koster F, Perlin DS, Park S, Brasel T, Gigliotti A, Barr E, Myers L, Layton RC, Sherwood R, Lyons CR. Milestones in progression of primary pneumonic plague in cynomolgus macaques. Infect Immun 2010; 78:2946 - 55; http://dx.doi.org/10.1128/IAI.01296-09; PMID: 20385751
   PubMed Web of Science ®Google Scholar
• Tian G, Qiu Y, Qi Z, Wu X, Zhang Q, Bi Y, Yang Y, Li Y, Yang X, Xin Y, et al. Histopathological observation of immunized rhesus macaques with plague vaccines after subcutaneous infection of Yersinia pestis.. PLoS One 2011; 6:e19260; http://dx.doi.org/10.1371/journal.pone.0019260; PMID: 21559437
   PubMedGoogle Scholar
• Feodorova VA, Corbel MJ. Prospects for new plague vaccines. Expert Rev Vaccines 2009; 8:1721 - 38; http://dx.doi.org/10.1586/erv.09.129; PMID: 19943765
   PubMed Web of Science ®Google Scholar
• Yang F, Ke Y, Tan Y, Bi Y, Shi Q, Yang H, Qiu J, Wang X, Guo Z, Ling H, et al. Cell membrane is impaired, accompanied by enhanced type III secretion system expression in Yersinia pestis deficient in RovA regulator. PLoS One 2010; 5:e12840; http://dx.doi.org/10.1371/journal.pone.0012840; PMID: 20862262
   PubMed Web of Science ®Google Scholar
• Zhou D, Tong Z, Song Y, Han Y, Pei D, Pang X, Zhai J, Li M, Cui B, Qi Z, et al. Genetics of metabolic variations between Yersinia pestisbiovars and the proposal of a new biovar, microtus.. J Bacteriol 2004; 186:5147 - 52; http://dx.doi.org/10.1128/JB.186.15.5147-5152.2004; PMID: 15262951
   PubMed Web of Science ®Google Scholar
• Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E, Chanteau S. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. ClinDiagn Lab Immunol 1997; 4:587 - 91; PMID: 9302210
   PubMed Web of Science ®Google Scholar
• Rohr LR, Layfield LJ, Wallin D, Hardy D. A comparison of routine and rapid microwave tissue processing in a surgical pathology laboratory.Quality of histologic sections and advantages of microwave processing. Am J ClinPathol 2001; 115:703 - 8; http://dx.doi.org/10.1309/15FB-FLD1-408X-JQA3; PMID: 11345834
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhuo F-L, Zhang S-J, Tian Y, Tian S, Zhang J-Z. Modulation of tropoelastin and fibrillin-1 by infrared radiation in human skin in vivo. PhotodermatolPhotoimmunolPhotomed 2009; 25:310 - 6; http://dx.doi.org/10.1111/j.1600-0781.2009.00465.x; PMID: 19906166
   PubMedGoogle Scholar
• Chen S, Cheng A, Wang M, Zhu D, Luo Q, Liu F, Chen X. Immunohistochemical detection and localization of new type gosling viral enteritis virus in paraformaldehyde-fixed paraffin-embedded tissue. Vet ImmunolImmunopathol 2009; 130:226 - 35; http://dx.doi.org/10.1016/j.vetimm.2009.02.011; PMID: 19304327
   PubMed Web of Science ®Google Scholar